Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD Study of HEC83518 in Healthy Chinese Subjects
NCT04596007Phase 1Completed
- Sponsor
- Sunshine Lake Pharma
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia comparing HEC83518 tablets with placebo tablets (2 arms). Primary endpoint: Number of Adverse Events at 5 days. Started Apr 2020; status: completed.
02
Drugs
HEC-83518
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04596007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596007.